Skip to main content

Table 4 QOLRAD and four symptoms questionnaire baseline scores and mean change scores after 4 week treatment with PPI

From: The impact of illness in patients with moderate to severe gastro-esophageal reflux disease

Instrument

Mean baseline score (95% CI)

Mean change score (95% CI)

QOLRAD emotional Distress

4.5 (4.3, 4.7) (N = 217)

2.0 (1.9, 2.2) (N = 217)

QOLRAD sleep Disturbance

4.5 (4.3, 4.7) (N = 217)

2.1 (1.9, 2.3) (N = 217)

QOLRAD food/drink problems

3.8 (3.7, 4.0) (N = 217)

2.5 (2.3, 2.6) (N = 217)

QOLRAD physical/social

5.5 (5.3, 5.6) (N = 217)

1.3 (1.1, 1.4) (N = 217)

QOLRAD vitality

4.3 (4.1, 4.5) (N = 217)

2.1 (1.9, 2.3) (N = 217)

Stomach pain

3.9 (3.7, 4.1) (N = 217)

-1.9 (-2.2, -1.7) (N = 217)

Heartburn

4.5 (4.3, 4.7) (N = 217)

-2.9 (-3.1, -2.7) (N = 216)

Belching

3.6 (3.4, 3.8) (N = 216)

-1.6 (-1.8, -1.4) (N = 216)

Acid reflux

4.1 (3.9, 4.3) (N = 215)

-2.4 (-2.6, -2.2) (N = 212)

  1. QOLRAD: Quality of life in reflux and dyspepsia, PPI: Proton pump inhibitor